Extracellular vesicle-associated proteins as potential biomarkers
© 2020 Elsevier Inc. All rights reserved..
Every cell in the body secretes extracellular vesicles (EVs) possibly as cellular signaling components and these cell-derivatives can be found in multiple numbers in biological fluids. EVs have in the scientific field received great attention in relation to pathophysiology and disease diagnostics. Altered protein expressions associated with circulating EVs in diseased individuals can serve as biomarkers for different disease states. This capacity paves the way for non-invasive screening tools and early diagnostic markers. However, no isolation method of EVs has been acknowledged as the "golden standard," thus reproducibility of the studies remains inadequate. Increasing interest in EV proteins as disease biomarkers could give rise to more scientific knowledge with diagnostic applicability. In this chapter, studies of proteins believed to be associated with EVs within cancer, autoimmunity, metabolic and neurodegenerative diseases have been outlined.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:99 |
|---|---|
| Enthalten in: |
Advances in clinical chemistry - 99(2020) vom: 01., Seite 1-48 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Schou, Anne Sophie [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 28.04.2021 Date Revised 28.04.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/bs.acc.2020.02.011 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM315229780 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM315229780 | ||
| 003 | DE-627 | ||
| 005 | 20231225154447.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/bs.acc.2020.02.011 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1050.xml |
| 035 | |a (DE-627)NLM315229780 | ||
| 035 | |a (NLM)32951635 | ||
| 035 | |a (PII)S0065-2423(20)30023-8 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Schou, Anne Sophie |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Extracellular vesicle-associated proteins as potential biomarkers |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 28.04.2021 | ||
| 500 | |a Date Revised 28.04.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2020 Elsevier Inc. All rights reserved. | ||
| 520 | |a Every cell in the body secretes extracellular vesicles (EVs) possibly as cellular signaling components and these cell-derivatives can be found in multiple numbers in biological fluids. EVs have in the scientific field received great attention in relation to pathophysiology and disease diagnostics. Altered protein expressions associated with circulating EVs in diseased individuals can serve as biomarkers for different disease states. This capacity paves the way for non-invasive screening tools and early diagnostic markers. However, no isolation method of EVs has been acknowledged as the "golden standard," thus reproducibility of the studies remains inadequate. Increasing interest in EV proteins as disease biomarkers could give rise to more scientific knowledge with diagnostic applicability. In this chapter, studies of proteins believed to be associated with EVs within cancer, autoimmunity, metabolic and neurodegenerative diseases have been outlined | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Autoimmunity | |
| 650 | 4 | |a Biological fluids | |
| 650 | 4 | |a Biomarker | |
| 650 | 4 | |a Cancer | |
| 650 | 4 | |a Diagnostic | |
| 650 | 4 | |a EVs | |
| 650 | 4 | |a Exosomes | |
| 650 | 4 | |a Extracellular vesicles | |
| 650 | 4 | |a Human | |
| 650 | 4 | |a Metabolic disease | |
| 650 | 4 | |a Microparticles | |
| 650 | 4 | |a Neurodegenerative disorders | |
| 650 | 4 | |a Protein expression | |
| 650 | 7 | |a Biomarkers |2 NLM | |
| 650 | 7 | |a Proteins |2 NLM | |
| 700 | 1 | |a Nielsen, Jonas Ellegaard |e verfasserin |4 aut | |
| 700 | 1 | |a Askeland, Anders |e verfasserin |4 aut | |
| 700 | 1 | |a Jørgensen, Malene Møller |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Advances in clinical chemistry |d 1958 |g 99(2020) vom: 01., Seite 1-48 |w (DE-627)NLM000045780 |x 2162-9471 |7 nnns |
| 773 | 1 | 8 | |g volume:99 |g year:2020 |g day:01 |g pages:1-48 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/bs.acc.2020.02.011 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 99 |j 2020 |b 01 |h 1-48 | ||